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Introduction
Hematopoiesis, which is the formation and development of blood 
cells, represents one of the best-studied models of cellular differ-
entiation. While dozens of blood cell lineages have been identi-
fied, all can be traced back to hematopoietic stem cells (HSCs) 
as the common progenitor. HSCs continually renew themselves 
to maintain a pool of blood stem cells; however, upon stimula-
tion by cytokines, HSCs give rise to multipotent progenitor cells 
(hematopoietic multipotent cells: HPCs) with restricted differen-
tiation potential, which can further develop into various termi-
nally differentiated blood cells.1-3 The diversity of cell types and 
clear tractability of cell differentiation pathways makes hemato-
poiesis a very attractive model for the investigation of cellular 
differentiation.
Cells of different identities have unique gene expression 
profiles, which are hierarchically regulated by interactions of 
transcription factors (TFs).4 Cellular differentiation, the trans-
formation of a cell from one identity (i.e., progenitor cells) to 
another (i.e., progeny cells), can be attributed to the alternation 
of varying TF complexes. Over the last two decades, the involve-
ment of key TFs in establishing specific hematopoietic lineages 
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has been revealed.1,5 A recent genome-wide characterization of 
the binding sites of ten hematopoietic-specific TFs in a blood 
progenitor cell line highlighted the multi-player nature of the TF 
complexes involved in hematopoiesis.6
The histone octamer, on which the DNA of eukaryotic 
organisms is wound, plays a pivotal role in the regulation of gene 
expression primarily through conformational changes, which 
control the accessibility of the transcriptional machinery to a 
DNA segment. The N-terminal tails of histones are subjected 
to various covalent chemical modifications, such as methylation, 
acetylation and ubiquitination. Recent histone modification 
ChIP-seq assays (chromatin immunoprecipitation coupled with 
high-throughput sequencing) have provided an extraordinarily 
detailed atlas of histone modifications at a genome-wide scale.7-10 
The availability of these resources prompted a series of follow-up 
studies that expanded the arsenal of computational tools in bio-
informatics and shed light on the roles that histone modifications 
may play in gene transcription.11-14
It has been established that histone modifications vary in 
their distribution over a certain genomic region and the direc-
tion in which they are linked to gene expression levels. Indeed, 
H3K4me3 is enriched at the TSS (transcription start site) and © 2012 Landes Bioscience.
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transcription factors described in the literature to be unambigu-
ously involved in hematopoiesis. The gene names, which encode 
the candidate hematopoietic-specific transcription factors, were 
queried against HGNC database (www.genenames.org) to obtain 
the corresponding Ensembl and RefSeq gene IDs. Second, as an 
alternative approach, the list of 1,391 curated, human TFs4 was 
uploaded to DAVID (david.abcc.ncifcrf.gov) to identify anno-
tations for each TF. Each annotation was manually checked to 
determine if a given TF was specific to hematopoiesis. Using this 
method, approximately 60 hematopoietic-specific TF genes were 
identified. Finally, the two TF lists were combined to obtain the 
final version consisting of 63 hematopoietic-specific TFs, which 
were of good representation and comprehensive coverage. The 
final list of HPTFs containing the gene symbols and Ensembl 
and RefSeq IDs is available in additional file 1.
TFs with higher histone modification variation scores were 
significantly enriched in the HPTF list. Following the pipeline 
illustrated in Figure 1, histone modification variation scores for 
all 1,329 TFs in 4 blood cell lineages were calculated for each 
histone mark (see Materials and Methods for details). For a given 
TF, when calculating the variation score for a histone mark, the 
maximum Euclidean distance between two cells was used as the 
histone variation score for the TF. Based on our method, histone 
modification variation scores of TFs fall into four categories [i.e., 
“high,” “medium,” “low” or “none” (no observable variation)].
Using the list of HPTFs obtained through literature mining, 
comparisons of the histone modification variation scores between 
HPTFs and non-HPTFs were performed. Significant differences 
between these two groups of TFs could be appreciated in terms 
of histone modification variations (Fig. 2). In general, the major-
ity of non-HPTFs were characterized by low-to-no variation for 
all histone marks (e.g., 85.4% of non-HPTFs show low-to-no 
variation in H3K4me3 levels). This trend also holds, to some 
extent, for HPTFs (e.g., 63.5% of the HPTFs show low-to-no 
variation in H3K4me3 levels). However, in the HPTF list, TFs 
with medium or high variation scores for all the three histone 
marks were significantly enriched. The enrichment for TFs with 
high variation scores was even more dramatic. Indeed, 12.7% 
of the HPTFs showed high variation in terms of H3K4me3 lev-
els, whereas only 1.5% of the non-HPTFs were characterized by 
high variation in H3K4me3 levels (Fisher exact test p value = 
1.775 x 10-5). Taken together, during blood cell differentiation, 
HPTFs, on average, were associated with more dramatic chroma-
tin dynamics compared with non-HPTFs.
Hierarchical clustering analysis defined a group of TFs 
where HPTFs were extraordinarily enriched. Our results indi-
cate that HPTFs, on average, had higher variation scores for 
any histone mark during blood cell differentiation. However, 
because chromatin states are often dictated by combinatorial 
histone marks and each histone also has its specific implications, 
we explored the combinatorial histone modification variations 
across all TFs. In an attempt to find some combinatorial his-
tone modification variation patterns that may be common in 
HPTFs, a hierarchical clustering analysis was performed. Each 
TF was represented by 3 values corresponding to variation scores 
for H3K4me3, H3K27me3 and H3K36me3. We cut the tree 
is often associated with gene activation.7 H3K36me3, an active 
mark highly correlated with transcriptional elongation, spreads 
over the entirety of the gene, peaking at the TTS (transcrip-
tion termination site).7 H3K27me3 is a repressive mark that can 
stretch from the promoter region of a gene to regions downstream 
of the TTS.7 Intuitively, one may postulate that histone modifica-
tions are connected to gene expression levels. Through the use of 
computational measures, it has been shown that histone modifi-
cations are indeed predictive of gene expression levels.15
While disputes may remain over whether the role of histone 
modification in gene expression is causal or concomitant, it has 
been established that certain combinatorial histone modification 
patterns have significant implications on gene expression during 
cellular differentiation. Bivalent genes, concurrently marked with 
both H3K4me3 and H3K27me3, were first identified as being 
abundant in embryonic stem cells (ES cells).16 Over time, the 
significance of bivalency in stem cell differentiation has been bet-
ter understood. In fact, bivalency represents a parsimonious and 
fixable mechanism that enables either activation, by removing 
H3K27me3 or repression, by removing H3K4me3 during cellu-
lar differentiation. Previous studies focused on the global histone 
modification dynamics during cellular differentiation.17,18 For 
instance, by comparing the epigenomic landscapes of human ES 
cells, Hawkins et al. found that the repressive marks, H3K9me3 
and H3K27me3, expand significantly in fibroblasts.18
Characterization of the histone modification dynamics 
from a loci-specific perspective during cellular differentiation 
holds promise to determine key players for the cellular differ-
entiation process. To verify our hypothesis, we investigated the 
histone modification variations of human transcription factors 
(TFs) using a publicly available, histone modification ChIP-seq 
data set containing four blood cell lineages, including CD133+ 
cells (HSCs/HPCs),19 CD36+ cells (erythrocyte precursors),19 
GM12878 cells (B lymphoblastoid) and CD4+ T cells. We sought 
to establish a method to assess the variations of histone modifica-
tions across cellular differentiation states. Our results indicated 
that, in most cases, hematopoietic-specific TFs are characterized 
by higher histone modification variations. Hierarchical clustering 
analysis of all curated human TFs, based on three histone modifi-
cation variation scores, defined a group of TFs where known and 
potential hematopoietic-specific TFs were remarkably enriched. 
Our method can be applied to other cellular systems and prom-
ises to be a useful tool for the de novo discovery of TFs of lineage-
specific functions.
Results and Discussion
Collection of a comprehensive gene list of hematopoietic-spe-
cific transcription factors. Two different approaches were used in 
parallel to generate a relatively comprehensive gene list of hema-
topoietic-specific transcription factors (HPTFs). First, keywords 
encompassing the names of a wide range of hematopoietic cells 
(such as blood stem cells, lymphocytes, T cells, B cells and ery-
throids) were used to retrieve articles from the PubMed database. 
By manually checking over 2,000 preliminarily matched titles 
and corresponding abstracts, we identified approximately 50 © 2012 Landes Bioscience.
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almost all three histone mark levels. Although TFs in Groups 
B-D showed major variations in H3K4me3, H3K27me3 and 
H3K36me3 respectively, there was no dramatic enrichment of 
HPTFs in any of the three groups. Noticeably, the TFs in Group 
E were characterized by major variations for both H3K4me3 and 
H3K36me3, while 66.7% of the TFs in Group E showed high/
medium variations in H3K27me3 levels.
Histone modification dynamics of TFs correlated with their 
lineage-specific functions. Our method enabled a systematic 
assessment of histone modification dynamics of all TFs during 
blood cell differentiation. These results show that HPTFs have 
dramatic histone modification variations during these processes. 
It would be highly desirable to investigate whether these dra-
matic histone modification dynamics of HPTFs have functional 
implications. To this end, we focused on the HPTFs belonging 
to Group E. Loci-specific wiggle (WIG) files were generated 
from the ChIP-seq BED files and uploaded to the UCSC genome 
browser as custom tracks. Combinatorial signals of the three his-
tone marks could define the chromatin state of the correspond-
ing gene. As shown in Figure 5, GATA1 was characterized by 
low signals of both H3K4me3 and H3K36me3 and high signals 
for H3K27me3, a typical repressed state. In erythrocyte precur-
sor cells, the signal for H3K4me3 was sharply increased, while 
significant signals for H3K36me3 were observed, and the signal 
for H3K27me3 was decreased. In contrast, GATA1 in B lympho-
blastoid cells remained in a repressed state. GATA1 is a known 
TF that functions in erythrocyte differentiation but does not 
play a role in lymphocyte development; therefore, the chromatin 
generated by hierarchical clustering into five clusters, and the 
overlap of TFs of each cluster with the HPTF list was inves-
tigated (Fig. 3 and Table 1). As shown in Table 1, 9 out of 
21 (43%) TFs in Group E are known to be HPTFs. Because 
the HPTFs represent less than 5% of the total TFs (63/1,329), 
there is an extraordinary enrichment of HPTFs in Group E   
(p value = 5.6 x 10-9).
Curious about the functions of the remaining 12 TFs in Group 
E that did not match HPTFs list, we checked the annotations for 
these 12 TFs in Biogps (biogps.org). Surprisingly, six TFs dis-
played either blood cell-specific expression patterns or are known 
to interact with HPTFs (Table 2). As illustrated in Figure 4, 
RUNX3 is exclusively expressed in blood cells, and there is in vivo 
evidence indicating that RUNX3 interacts with AML, a known 
HPTF (Table 2). Therefore, it is highly likely that RUNX3 is a 
potential HPTF.
The remarkable enrichment of HPTFs in Group E could lead 
to the conclusion that some TFs of related or similar functions 
(e.g., involvement in hematopoiesis) in a set of cells share simi-
lar combinatorial histone modification variation patterns during 
cellular differentiation. A closer look into the five groups of TFs 
(Groups A-E) revealed marked differences in terms of histone 
modification variation patterns (Table 1). Group A comprised 
the largest number of TFs (893 in total), and none of the TFs in 
Group A showed medium/high variation in H3K4me3 levels or 
H3K27me3 levels. Only 10.9% of the TFs in Group A showed 
medium/high variations in H3K36me3 levels. Therefore, in gen-
eral, TFs in Group A were characterized by minor variations for 
Figure 1. Schematic representation of the analysis pipeline.© 2012 Landes Bioscience.
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sensitivity than that of microarray (p < 0.001), the rest two histone 
marks (H3K4me3 and H3K27me3) were both inferior to micro-
array due to significantly lower sensitivities (p < 0.001). When it 
comes to double or triple histone marks, again their sensitivities 
were largely compromised. However, in any case of the combina-
tions of histone marks, the specificity always outperformed that 
of microarray. As it was assessed by MCC (Matthews correlation 
coefficient), a balanced measure that takes into account true and 
false positives and negatives, microarray only showed a moder-
ate performance, e.g., H3K36me3 coupled with H3K4me3 was 
superior to microarray.
In summary, when it comes to the comparison of predic-
tive performance of our epigenetical approach with microarray 
method, we have shown that H3K36me3 alone is at least as good 
as microarray in both sensitivity and specificity. This result stands 
to reason as H3K36me3 density as assigned to a gene is explic-
itly linked to the gene expression level.7 However, the other two 
histone marks, namely H3K4me3 and H3K27me3, are linked 
to gene expression level in a much more subtle way. H3K4me3 
marks the promoter regions and corresponds to RNAP II bind-
ing sites, however, RNAP II binding does not necessarily mean 
gene transcription actually occurs.20 Besides, H3K27me3, an 
dynamics of GATA1 during blood cell differentiation perfectly 
matches its function.
Two more examples are shown in Figure 5, namely Aiolos and 
PAX5, both of which have been reported to function specifically 
during B lymphocyte development. The chromatin states of these 
two genes become selectively activated in B lymphoblastoid cells 
(Fig. 5).
Comparison of the predictive performance of our method 
with that of microarray method. By systematic assessment of 
histone modification dynamics of TFs during blood cell dif-
ferentiation, we have shown that, HPTFs tend to have higher 
histone modification variations. In addition, clustering analysis 
has revealed that, TFs with simultaneous high variations for 
H3K4me3, H3K27me3 and H3K36me3 are more likely to be 
TFs with lineage-specific functions. These observations point to 
the possibility of predicting TFs with lineage-specific functions 
by assessing histone modification dynamics (hereafter refered to 
as the epigenetical approach).
We made predictions of HPTFs using the methods as detailed 
in the Materials and Method section. As it is shown in Table 3, 
single histone marks all showed similar specificities as that of 
microarray. While H3K36me3 displayed a significantly higher 
Figure 2. HPTFs are characterized by increased histone modification variations during blood cell differentiation. The radar plot has four poles, each 
corresponding to a level of histone modification variation. Level of variation is designated as “none,” “low,” “medium” and “high.” On each of the four 
axes, the percentage of TFs with a corresponding histone modification variation level is noted. For a given histone mark, points representing the varia-
tion levels on the four axes are connected sequentially. Different histone marks are illustrated by different colors. Dashed lines depict the variations of 
other TFs (apart from HPTFs) and solid lines depict the variations of HPTFs.© 2012 Landes Bioscience.
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raw data of CD133+ cells (HSCs/HPCs), CD36+ cells (erythro-
cyte precursors), and GM12878 cells (B lymphoblastoid) were 
downloaded as FASTQ format files. The Solexa short reads were 
mapped to the human genome using Bowtie (index file: hg19.
fa) with default parameters.22 Each of the three histone modifi-
cation ChIP-seq data sets of CD4+ T cells were downloaded as 
BED format files. Because the BED files were generated based 
on human genome assembly hg18, LiftOver (UCSC genome 
browser) was used to transform the hg18-based BED files into 
hg19-based BED files. The detailed information concerning the 
sources of the histone modification data and cell identities is 
described in additional file 2. PCR redundancies were removed 
from all BED files by counting the multiple reads that mapped 
to the same genomic position (i.e., chromosome names, start and 
earlier defined repressive mark, has been revealed to play a more 
complex role in differentiation than one has appreciated over the 
last few years.16 It has been very recently reported that, in some 
way, H3K27me3 densities could be positively associated with 
gene expression levels.21 Our results suggest that, when there are 
ChIP-seq data available for multiple histone marks in different 
cell lineages sharing the same progenitor cells, it holds promise to 
really capture some crucial TFs by picking those TFs of simulta-
neous high variations for multiple histone marks.
Materials and Methods
Histone modification ChIP-seq raw data collection and prepro-
cessing. The H3K4me3, H3K27me3 and H3K36me3 ChIP-seq 
Figure 3. Hierarchical clustering of all TFs based on the variation scores of three histone marks. The tree was cut into five groups, each encompassing a 
variable number of TFs. The order of the groups (A to E) was based on the group size.
Table 1. Features of the five subclasses of TFs and overlap with HPTFs
Subclass H3K4me3 variations (%) H3K27me3 variations (%) H3K36me3 variations (%) Overlap with HPTFs
A (893) N/La 100.0 N/L100.0 N/L 89.1
19 (2.1%)
M/Hb 0.0 M/H 0.0 M/H 10.9
B (177) N/L 0.0 N/L 80.2 N/L 68.4
11 (6.2%)
M/H 100.0 M/H 19.8 M/H 31.6
C (145) N/L 95.2 N/L 0.0 N/L 69.0 17 (11.7%) 
p = 1.4 x 10−5 M/H 4.8 M/H 100.0 M/H 31.0
D (93) N/L 96.8 N/L 96.8 N/L 0.0
7 (7.5%)
M/H 3.2 M/H 3.2 M/H 100.0
E (21) N/L 0.0 N/L 33.3 N/L 0.0 9 (42.9%) 
p = 5.6 x 10−9 M/H 100.0 M/H 66.7 M/H 100
avariation or no variation bmedium or high variation. Approximately 4.7% of the total human TFs are HPTFs.
Table 2. Potential HPTFs in Group E
Ensembl ID Gene symbol Expression pattern Interaction with known HPTFs
ENSG00000020633 RUNX3 Exclusively in blood cells AML
ENSG00000078399 HOXA9 Colon and blood cells MEIS1
ENSG00000137265 IRF4 Exclusively in B lymphoblasts and dendritic cells STAT6, BCL6 and SPI1
ENSG00000081189 MEF2C Fetal brain and blood cells -
ENSG00000140968 IRF8 Exclusively in blood cells -
ENSG00000178860 MSC Exclusively in B lymphoblasts E2A© 2012 Landes Bioscience.
Do not distribute.
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Figure 4. Two potential HPTFs within group E show blood cell-specific expression patterns. A total of 84 human cell lines or primary tissues were 
characterized by expression profiling. Tissues or cell lines, denoted by numbers with black colors, represent a broad range of non-blood tissues (or 
cell lines), such as kidney, thymus, liver, lung, prostate, heart and others. Red numbers 28–37 denote MOLT-4, K562, lymphoma, HL60, Raji and early 
erythroid cells. Red numbers 74 to 84 denote CD34+ cells, B lymphoblasts, CD19+ B cells, dendritic cells, CD8+ T cells, CD4+ T cells, CD56+ NK cells, CD33+ 
myeloid cells, CD14+ monocytes and whole blood. The expression profiles for MSC and RUNX3 were obtained from Biogps (biogps.org).
Figure 5. Visualization of the histone modification dynamics of some HPTFs. From left to right, the histone modification profiles are displayed for the 
genomic loci of HPTFs GATA1, Aiolos and PAX5 in CD133+ cells (HSCs/HPCs), CD36+ cells (erythrocyte precursors), GM12878 cells (B lymphoblastoids) and 
CD4+ T cells. The histone modification ChIPseq tag wiggle files were uploaded to the UCSC genome browser and visualized as custom tracks. The parts 
in red, black and blue denote the profiles of H3K4me3, H3K27me3 and H3K36me3, respectively. The structures of genes are shown at the top parts.© 2012 Landes Bioscience.
Do not distribute.
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histone modification density vector for a given cell type, and 
the medians were used to define the boundaries. The histone 
modification tag densities (H, M, L and LL) corresponded to the 
numeric values 4, 3, 2 and 1. For a given histone modification 
type, each TF was represented by a vector of four numerical val-
ues representing the histone modification levels of the four blood 
cell lineages. For a given histone modification type, the histone 
modification variation score (HMV) for a given TF in each of 
the 4 blood cell lineages was calculated using the formula:
HMV = max {Dist (Ci, Cj)} where 1 ≤ i < j ≤ 4
Ci represents a specific blood cell lineage and is characterized 
by discrete values for the three histone marks. “Dist” represents 
the Euclidian distance of Ci and Cj. Because each histone modi-
fication was categorized into 4 levels, the HMV was also repre-
sented by 4 levels (i.e., 0, 1–3).
Microarray data analysis and prediction of HPTFs by micro-
array data and histone modification dynamics. The microar-
ray raw data for the four types of blood cells were downloaded 
from GEO database (GEO IDs are GSE12646, GSE26312). 
As these microarray raw data were from different platforms, it 
was not applicable to do expression indexing for them together 
(e.g., using RMA algorithm). Therefore, we performed present/
absent calls using MAS5.0 algorithm from Bioconductor package 
(www.bioconductor.org). The rationale for making prediction of 
HPTFs by microarray was that, if a TF encoding gene showed 
ON/OFF variations across the four blood cells, this TF was pre-
dicted as a HPTF.
In order to make prediction of HPTFs based on histone 
modification dynamics, we made binary partition of all TFs’ 
histone modification variation scores (i.e., combining histone 
modification variation scores “0” and “1” into “Low_V,” “2” and 
“3” into “High_V”). For each single histone mark, a TF with a 
“High_V” was predicted as a HPTF. When prediction was made 
based on more than one histone mark, a TF with simultaneous 
“High_Vs” was predicted. The list of 63 HPTFs as detailed in 
additional file 1 was used as the benchmark to compare the per-
formances of predictions made by microarray method, single 
histone marks and combinations of histone marks.
Conclusion
As epigenetics takes center stage, interest in unraveling the role 
of histone modifications during cellular differentiation is increas-
ing. Here, we presented a pipeline for assessing the histone 
end positions and strand types that were identical) before fur-
ther analysis was performed. This was performed to reduce noises 
attributable to genomic regional biases during the PCR amplifi-
cation step in the ChIP-seq assays.
Establishment of bin-based histone modification read count 
vectors of all curated human TFs. The 1,391 curated human TF 
gene IDs from the Ensembl Genome Browser (Ensembl) were 
downloaded from the Supplemental files of Vaquerizas et al.4  All 
gene IDs were uploaded to DAVID (david.abcc.ncifcrf.gov), and 
1,366 out of the 1,391 total Ensembl gene IDs could be unam-
biguously converted to RefSeq IDs. The genomic coordinates of 
the RefSeq IDs were extracted from the hg19 assembly based on 
the gene annotation sheet downloaded from the UCSC Table 
browser. Approximately 18 RefSeq IDs had multiple genomic 
coordinates, likely representing genome duplication. Because the 
role of histone modification in genome duplication is not within 
the scope of this study and no evidence has shown that there is a 
bias in the probabilities of certain classes of TFs being duplicated, 
these 18 RefSeq IDs were removed. There were also several cases 
where a given RefSeq ID was matched to multiple Ensembl IDs. 
A closer look into these cases revealed that redundant Ensembl 
IDs represented either pseudo-genes or alias IDs. In such cases, 
pseudo-genes was removed and only the most recently updated 
Ensembl IDs were kept for each given RefSeq ID. In the end, 
the genomic coordinates of 2,113 RefSeq IDs (representing 1,329 
ensemble gene IDs) were identified.
Each TF out of the total 2,113 RefSeq IDs was partitioned into 
14 bins. The first two bins were 2,000 basepairs (bp) upstream, 
1,000 bp upstream and 1,000 bp upstream of the TSS. The last 
two bins were from the TTS to 1,000 bp downstream, 1,000 bp 
downstream and 2,000 bp downstream. The open reading frame 
of each gene, from TSS to TTS, was partitioned into ten equal 
parts based on gene length.
To make comparisons of all TFs in terms of histone modifica-
tion variations, genes in the list of 1,329 TFs that had more than 
one corresponding RefSeq ID were represented by the RefSeq 
genes with longest transcripts.
Calculation of histone modification variation scores. For 
each cell type, histone modification tag densities, as calculated 
by dividing the read counts by window sizes (Fig. 1), were split 
into four nominal variables representing high, moderate, low 
and extremely low levels (dubbed H, M, L and LL, respectively). 
The boundaries between groups were determined by k-means 
clustering. One hundred repetitions were performed for each 
Table 3. Prediction of lineage-specific TFs
Performance Microarray
H3K4 
me3
H3K27 
me3
H3K36 
me3
H3K27me3 
& H3K4me3
H3K36 
me3 
& H3K4 
me3
H3K27 
me3 
& H3K36 
me3
H3K27me3 
& H3K4me3 
& H3K36me3
Specificity 81.6% 85.4% 86.5% 78.7% 96.5% 95.1% 94.9% 97.9%
Sensitivity 52.3% 36.5% 41.3% 66.7% 19.0% 31.7% 28.6% 15.9% 
MCC 0.18 0.13 0.17 0.23 0.16 0.24 0.20 0.18
A comparison of the epigenetical approach with microarray analysis© 2012 Landes Bioscience.
Do not distribute.
62  Epigenetics  Volume 7 Issue 1
Acknowledgments
The authors would like to thank Xiaole Shirley Liu, Tonghua 
Li, Jiangming Sun, Cizhong Jiang and Cheng Li for very help-
ful suggestions and critical comments. We thank Min Li, Meng 
Zhou and Kai Fu for help with downloading part of the raw 
data, and Tao Liu for sharing several python scripts. This study 
was supported by funding from the National Natural Science 
Foundation of China (31071114), the National Basic Research 
Program of China (973 Program; Nos. 2011CB965104  and 
2010CB944904) and the Shanghai Rising-Star Program 
(10QA1407300).
Note
Supplemental material can be found at:
www.landesbioscience.com/journals/epi/article/18683
modification variations of genes involved in hematopoietic dif-
ferentiation. Our results showed that, in most of cases, hema-
topoietic-specific TFs had higher variation scores for all three 
histone marks (H3K4me3, H3K27me3 or H3K36me3). These 
higher variations of histone modifications corresponding to 
hematopoietic-specific TFs represent dramatic chromatin state 
changes leading to the activation or repression of certain genes. 
Interestingly, clustering of TFs based on histone modification 
variation scores defined a group of TFs where known or poten-
tial hematopoietic-specific TFs were remarkably enriched. Our 
results strongly suggest that investigation of loci-specific chro-
matin dynamics during cellular differentiation holds promise to 
identify TFs of lineage-specific function.
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